.

Megadeth's Dave Mustaine Completes Cancer Treatment


William Lee | 10-29-2019

Share on Facebook Share on Twitter Pin it Share on Reddit email this article

Megadeth

Megadeth cofounder David Ellefson says that his bandmate Dave Mustaine is currently in recovery after completing treatment for throat cancer and says they are very optimistic.

Ellefson revealed the news during an interview with Pomelo Rocker. He shared, "With Dave's throat cancer treatments that he has now completed, and he's just going through the recovery now, we're hopeful and optimistic about a full recovery for him with that.

"Once he's through that process, we're gonna just let that take as much time as it needs, and then we'll resume with the album. I'd like to hope maybe 2020 we'll be able to get a new album out...

"Sometime life throws you cards you didn't expect. Megadeth, we've always been a resilient band and we've always just worked around obstacles. Dave's a fighter, as we know. Just talking to him, he sounds very optimistic about the future for Megadeth." Watch the interview


Related Stories


Megadeth and Lamb Of God Announce Coheadline Tour

Former Megadeth and Lamb Of God Stars Form New Project

Megadeth's Dave Mustaine Declared '100 Perfect Cancer Free'

Dave Mustaine's Daughter Performs With Megadeth

Megadeth's Dave Mustaine 'Back Better Than Ever' After Cancer Fight

Megadeth's Dave Mustaine Says 'I'm Back' Following Cancer Fight

Megadeth's Dave Mustaine Completes Cancer Treatment 2019 In Review

Cancer Diagnosis Was A Surprise To Megadeth Cofounder 2019 In Review

Megadeth's Dave Mustaine Diagnosed With Cancer 2019 In Review

Dave Mustaine Asked Dimebag To Join Megadeth 2019 In Review

More Megadeth News



advertisement

advertisement


Follow Us: Facebook Twitter Feeds

Contact Us - Privacy - antiMusic Email - Why we are antiMusic

Copyright© 1998 - 2020 Iconoclast Entertainment Group All rights reserved.

Please click here for legal restrictions and terms of use applicable to this site. Use of this site signifies your agreement to the terms of use.